Contact this trialFirst, we need to learn more about you.
LY3461767 for Heart Failure
Recruiting0 awardsPhase 1
Chapel Hill, North Carolina
This trial tests a new drug, LY3461767, for safety in people with a specific type of heart failure. The drug is given through a small tube under the skin for a few days. The study checks how the drug affects patients and how their bodies handle it.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service